UBS ASSET MANAGEMENT AMERICAS LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,027,985
+89.5%
50,170
+58.4%
0.00%
Q2 2023$542,5250.0%31,6710.0%0.00%
Q1 2023$542,525
-48.2%
31,671
-40.8%
0.00%
-100.0%
Q4 2022$1,046,428
-99.8%
53,471
+36.6%
0.00%
Q3 2022$624,642,000
+16.0%
39,1380.0%0.00%
Q2 2022$538,538,000
-13.2%
39,1380.0%0.00%
Q1 2022$620,728,000
-27.3%
39,1380.0%0.00%
Q4 2021$854,382,000
-39.8%
39,138
-17.6%
0.00%
-100.0%
Q3 2021$1,419,179,000
-34.4%
47,480
-2.8%
0.00%0.0%
Q2 2021$2,163,656,000
+30.6%
48,852
+30.8%
0.00%0.0%
Q1 2021$1,656,777,000
-14.8%
37,340
+5.3%
0.00%0.0%
Q4 2020$1,945,229,000
+139.9%
35,4710.0%0.00%
Q3 2020$810,868,000
+23.4%
35,471
+13.0%
0.00%
Q2 2020$657,013,000
+206.6%
31,391
+233.5%
0.00%
Q4 2019$214,262,000
+14.8%
9,414
-24.3%
0.00%
Q2 2019$186,570,00012,4380.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders